The Government Council approved at its meeting on Tuesday the signing of a contract for the supply of calendar vaccines for the residents of Castilla-La Mancha during 2024, worth almost 10 million euros (9,770,789.6 euros). Spokeswoman Esther Padilla made the announcement at a press conference on Wednesday, noting that the contract is divided into 16 tranches, totaling 321,250 doses.
The adviser called on citizens to go to health centers to get vaccinated against influenza and COVID-19. “Due to the abnormal temperatures in November, it looks like the cold will not come, but we must protect ourselves and survive the coldest winter,” as he suggested, ” over the next few months.”
Padilla stressed that thanks to the signing of the authorization, “the need for the procurement and supply of certain doses of vaccine products for next year is met, with the aim of adhering to the official vaccination calendar of our Autonomous Region.” In addition, he noted that “we are forward-looking, through With this purchase, we ensure that these vaccines will be available starting from January 1 next year.”
In this regard, the consultant assessed the capacity of the Public Health Service of Castile-La Mancha to cope with the vaccination system, as she recalled that “the García-Pec government has invested a total of 3000 million in vaccination against diseases in 2023” million euros, plus all the flu we tell you about today.
In his speech, the spokesperson of the Regional Executive recalled that next year, “we will take a further step to the tune of 39 million euros, or 9 million euros, to guarantee access to a broad vaccination catalog through the public health authorities. ” In fact, he stressed, Since García-Peche arrived in the government of Castile-La Mancha, “we have increased the vaccination budget by 700%”, recalling that “in 2015 only 5 million euros were invested; in 2023 we have invested 5 million euros”. 30 million, multiply that number by six and you can immunize a much larger portion of the region’s population. “
Additionally, Padilla recalled in his speech that the year is coming to an end and some new vaccines have been incorporated into the calendar. As he mentioned, “We are offering the human papillomavirus vaccine, meningococcal type B vaccine, shingles vaccine, bronchiolitis vaccine, and the ‘under 5 flu vaccine’ to infants starting October 1. “age. “
Padilla took stock of the flu campaign that began last October and informed the media that as of Friday, “224,500 doses of flu vaccine had been administered, 8,149 of which were given to children; this means that in less than In one month, we have already administered more than a third of the vaccines, which also reflects the trust that citizens place in our health and respond in this very positive way.” As the regional spokesperson concluded , in terms of COVID-19, a total of 153,700 doses of vaccine have been delivered in the current campaign.
Vaccines in the 2024 calendar
The vaccines purchased next year include 45,000 doses of hepatitis B, diphtheria, tetanus, acellular pertussis, inactivated polio and Haemophilus influenzae type B conjugate vaccine six-unit vaccine; a total of 24,000 doses of diphtheria, tetanus, acellular pertussis and inactivated polio vaccine; 250 doses of Haemophilus influenzae type B conjugate vaccine and an additional 12,000 doses of diphtheria, tetanus, and acellular pertussis vaccine with reduced antigen content.
Also included are 26,000 doses of diphtheria and tetanus vaccine with reduced antigen content; 19,000 doses of hepatitis B vaccine for children; 2,000 doses of hepatitis B vaccine for adults and 11,000 doses of hepatitis A vaccine for children.
The contract authorized by the government committee also includes 3,500 doses of hepatitis A vaccine for adults; 6,000 doses of measles, rubella and mumps vaccine; 20,000 doses of varicella vaccine, and an additional 28,000 doses of measles, rubella, mumps and varicella vaccine.
Finally, a total of 18,000 doses of meningococcal type C conjugate vaccine will be received; 26,500 doses of meningococcal group B vaccine; 45,000 doses of 9-valent HPV vaccine and 35,000 doses of 23-valent pneumococcal polysaccharide vaccine.
New Health Science Research Plan
On the other hand, consultant Esther Padilla reported another agreement from the Ministry of Health that was discussed by a government committee yesterday. This is the approval of the Health Sciences Research and Innovation Programme, which “aims to develop guidelines that will lay the foundation for the development and implementation of this matter and to drive new action and make visible and prominent the action already taken”. It is part of the Castilla-La Mancha Horizon 2025 health plan, which, as the Ministry of Health acknowledges, is “the road map that the Ministry of Health follows to implement its policies”.
In fact, he explained that this new plan will serve as a regulatory framework that will promote research and innovation in an environment conducive to the prevention and promotion of innovations in health, care and health services management, “which means that work will be carried out in autonomous regions of researchers,” he noted.
Additionally, Padilla emphasized that by combining resources and efforts, “we will continue to position ourselves as a region making great strides in science education.”